Pillar Clinical Research, a Texas-based, multi-specialty clinical research site network, announced on Wednesday that it has named Zach Mitchell as its new chief commercial officer.
In the new role, Mitchell is to head the company's commercial functions and strategy, and continue to execute the company's mission for research to be seen as a care option through community outreach initiatives.
Mitchell has a range of experience in the clinical research industry, spanning operations, business development and project management across multiple therapeutic indications and phases. He has most recently worked as executive director of strategic partnerships for CenExel Clinical Research. He has also served as director of business operations for iResearch Atlanta.
Neuspera Medical names new chief operating officer
GenScript Biotech Corporation names new board members
Alchemab Therapeutics names new CEO
Breg names new chief executive officer and chief financial officer